Albemarle (ALB)
(Delayed Data from NYSE)
$114.94 USD
-3.24 (-2.74%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $115.04 +0.10 (0.09%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum D VGM
Brokerage Reports
0 items in cart
Albemarle Corporation [ALB]
Reports for Purchase
Showing records 201 - 220 ( 773 total )
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Company: Albemarle Corporation
Industry: Chemical - Diversified
Chemicals: 3Q21 Preview - Sticking with Pricing Power
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Chemicals: 3Q21 Preview - Sticking with Pricing Power
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Company: Albemarle Corporation
Industry: Chemical - Diversified
Investor Day - 2026 Goals Reflect EV Growth; Are Shares Already There?
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Basic Materials: Thematic Update and What?s Priced In?
Provider: KEYBANC CAPITAL MARKETS
Analyst: GIBBS P
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Company: Albemarle Corporation
Industry: Chemical - Diversified
Company: Albemarle Corporation
Industry: Chemical - Diversified
2Q21 Follow-Up - Li Tolling Lifts 2H21, Projects on Track
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
2Q21 First Look - Results Modestly Positive; Lithium Improving with Tolling Providing Upside to Volumes
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department